Healthcare · Biotechnology
Is Elicio Therapeutics, Inc. (ELTX) Stock Halal?
Shariah Compliance Across 5 Standards — Live
Screen ELTX live and build a compliant portfolio
Live verdicts across 5 Shariah standards, financial ratios, segment-level business income, purification and Zakat — one workspace, always current.
Shariah Compliance Verdict — 5 Standards
AAOIFI (Shari'ah Standard 21)market-cap basis
cash/MC 47.3% > 30%
Dow Jones Islamic Marketmarket-cap basis
missing: interest_ratio
FTSE Shariah (Yasaar)total-assets basis
cash/assets 74.9% > 33%
MSCI Islamictotal-assets basis
cash/assets 74.9% > 33%
S&P Shariahmarket-cap basis
missing: interest_ratio
Live verdicts from the Halal Terminal screening engine, recomputed against the issuer's latest filings.
Plain-English Summary
Fails AAOIFI, FTSE, MSCI on cash/MC 47.3% > AAOIFI 30%; cash/assets 74.9% > FTSE 33%, MSCI 33%. DJIM, S&P insufficient data (missing: interest_ratio).
Business Activity Screen
Business activity is compliant.
Financial Ratios
Interest-bearing debt / market cap
AAOIFI ≤30% · DJIM/S&P <33% (trailing-avg MC)
20.1%
Cash & interest-bearing / market cap
AAOIFI ≤30% of market cap
47.3%
Debt / total assets
FTSE/MSCI <33.33% of total assets
31.9%
Cash & interest-bearing / total assets
FTSE/MSCI <33.33% of total assets
74.9%
Raw ratios from the latest filings — each methodology applies its own basis and thresholds (see the verdict box above for per-standard outcomes).
Balance-Sheet Trajectory (8 Quarters)
| Quarter end | Debt / assets | Cash / assets | Receivables + cash / assets |
|---|---|---|---|
| 2024-09-30 | 52.2% | 67.8% | 67.8% |
| 2024-12-31 | 71.1% | 62.5% | 62.5% |
| 2025-03-31 | 71.2% | 65.2% | 65.2% |
| 2025-06-30 | 31.6% | 74.8% | 74.8% |
| 2025-09-30 | 34.4% | 72.9% | 72.9% |
| 2025-12-31 | 38.7% | 71.8% | 71.8% |
| 2026-03-31 | 41.8% | 65.9% | 65.9% |
| 2026-06-30 | 30.4% | 74.9% | 74.9% |
A stock that has screened comfortably for eight straight quarters is a different story from one that crossed a threshold last quarter — trajectory shows which one this is.
Frequently Asked Questions
Is Elicio Therapeutics, Inc. (ELTX) halal to invest in?
Elicio Therapeutics, Inc. currently screens as non-compliant on the Halal Terminal engine. The verdict is recomputed against the issuer's latest financial filings and all five major methodologies (AAOIFI, DJIM, FTSE, MSCI, S&P) — see the per-standard breakdown above. This is a data-driven application of published standards, not a fatwa.
Is ELTX compliant under AAOIFI?
No — ELTX currently fails AAOIFI screening: cash/MC 47.3% > 30%.
Do I need to purify dividends from ELTX?
A purification rate could not be computed from the latest filings; consult the methodology page for how purification works.
Why do halal screening apps disagree about ELTX?
Different services apply different ratio bases (market capitalization vs total assets), different revenue classifications, and different data vintages. This page shows both AAOIFI readings side by side and classifies revenue segments explicitly so the source of any disagreement is visible.
Related Healthcare Stocks
All Healthcare →Hims & Hers Health, Inc.
Healthcare
Johnson & Johnson
Healthcare
Pfizer Inc.
Healthcare
Eli Lilly and Company
Healthcare
Intuitive Surgical, Inc.
Healthcare
Amgen Inc.
Healthcare
Abbott Laboratories
Healthcare
Profusa, Inc.
Healthcare
Screen your full portfolio, not just one stock
Live verdicts across 5 Shariah standards, financial ratios, segment-level business income, purification and Zakat — one workspace, always current.
Disclaimer: This page is for educational and informational purposes only and does not constitute financial or religious advice. Verdicts and figures come from the Halal Terminal screening engine, computed from the issuer's public financial filings and refreshed regularly (last screened 2026-09-20). This is a data-driven application of published Shariah standards — not a fatwa. Consult a qualified Islamic finance scholar or advisor for personalised guidance.